On the dynamics of neutral mutations in a mathematical model for a homogeneous stem cell population
暂无分享,去创建一个
Tom Lenaerts | Arne Traulsen | Jorge M Pacheco | David Dingli | A. Traulsen | T. Lenaerts | D. Dingli | J. M. Pacheco
[1] M. Kimura,et al. DNA and the neutral theory. , 1986, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[2] A. Risitano,et al. Eculizumab treatment modifies the immune profile of PNH patients. , 2012, Immunobiology.
[3] Jeremy M. Stark,et al. Chronic myelogenous leukemia stem and progenitor cells demonstrate chromosomal instability related to repeated breakage-fusion-bridge cycles mediated by increased nonhomologous end joining. , 2012, Blood.
[4] J Gilbert,et al. Theoretical introduction , 2019, Gender Terrains in African Cinema.
[5] A. W. F. Edwards,et al. The statistical processes of evolutionary theory , 1963 .
[6] Peter Guttorp,et al. Evidence that hematopoiesis may be a stochastic process in vivo , 1996, Nature Medicine.
[7] A. Strasser,et al. Is tumor growth sustained by rare cancer stem cells or dominant clones? , 2008, Cancer research.
[8] J. Birch. Genes and cancer , 1999, Archives of disease in childhood.
[9] M. Kimura,et al. An introduction to population genetics theory , 1971 .
[10] S. Marley,et al. Chronic myeloid leukaemia: stem cell derived but progenitor cell driven. , 2005, Clinical science.
[11] P. Jagers,et al. Branching Processes: Variation, Growth, and Extinction of Populations , 2005 .
[12] A Traulsen,et al. Progenitor cell self‐renewal and cyclic neutropenia , 2009, Cell proliferation.
[13] Aleksandar Dakic,et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.
[14] Ken Kurokawa,et al. Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH). , 2006, Blood.
[15] Arne Traulsen,et al. Stochastic Dynamics of Hematopoietic Tumor Stem Cells , 2007, Cell cycle.
[16] Marek Kimmel,et al. Branching processes in biology , 2002 .
[17] S M Lewis,et al. Natural history of paroxysmal nocturnal hemoglobinuria. , 1995, The New England journal of medicine.
[18] Jorge M Pacheco,et al. Neutral evolution in paroxysmal nocturnal hemoglobinuria , 2008, Proceedings of the National Academy of Sciences.
[19] G. Bell. Fluctuating selection: the perpetual renewal of adaptation in variable environments , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.
[20] C. Verfaillie,et al. A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector. , 2001, Blood.
[21] Lucio Luzzatto,et al. Somatic Mutations in Paroxysmal Nocturnal Hemoglobinuria: A Blessing in Disguise? , 1997, Cell.
[22] W. Ewens. Mathematical Population Genetics , 1980 .
[23] David A. Williams,et al. Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. , 2012, Blood.
[24] Jl Lewis,et al. Discordant erythropoiesis in CML , 1998, Leukemia.
[25] Lucio Luzzatto,et al. The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH). , 2006, Blood.
[26] Neal Young,et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. , 2005, Blood.
[27] Y. Kanakura,et al. Deregulated expression of HMGA2 is implicated in clonal expansion of PIGA deficient cells in paroxysmal nocturnal haemoglobinuria , 2012, British journal of haematology.
[28] A. Traulsen,et al. Evolutionary dynamics of chronic myeloid leukemia. , 2010, Genes & cancer.
[29] P. Holgate,et al. Branching Processes with Biological Applications , 1977 .
[30] D. Alling,et al. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. , 1985, The Journal of clinical investigation.
[31] Arne Traulsen,et al. Somatic mutations and the hierarchy of hematopoiesis , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.
[32] Arne Traulsen,et al. On the Origin of Multiple Mutant Clones in Paroxysmal Nocturnal Hemoglobinuria , 2007, Stem cells.
[33] M. Stratton,et al. The cancer genome , 2009, Nature.
[34] W. Ewens. Mathematical Population Genetics : I. Theoretical Introduction , 2004 .
[35] D. Tenen,et al. BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells. , 2010, Blood.
[36] A. Traulsen,et al. Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cells , 2009, Haematologica.
[37] S. Richards,et al. The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab , 2009, Therapeutics and clinical risk management.
[38] John Cairns,et al. Mutation selection and the natural history of cancer , 1975, Nature.
[39] Arne Traulsen,et al. Multiple mutant clones in blood rarely coexist. , 2008, Physical review. E, Statistical, nonlinear, and soft matter physics.
[40] L. Luzzatto,et al. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria , 1994, The Lancet.
[41] P. Moran,et al. The statistical processes of evolutionary theory. , 1963 .
[42] T. Antal,et al. Fixation of Strategies for an Evolutionary Game in Finite Populations , 2005, Bulletin of mathematical biology.
[43] Anirvan M. Sengupta,et al. Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. , 2003, Journal of theoretical biology.
[44] A. Traulsen,et al. Reproductive fitness advantage of BCR-ABL expressing leukemia cells. , 2010, Cancer letters.
[45] Jorge M. Pacheco,et al. Allometric Scaling of the Active Hematopoietic Stem Cell Pool across Mammals , 2006, PloS one.
[46] Benjamin D. Simons,et al. Defining the mode of tumour growth by clonal analysis , 2012, Nature.
[47] A. Traulsen,et al. Fixation times in evolutionary games under weak selection , 2008, 0812.0851.
[48] T. Brümmendorf,et al. Dynamics of Resistance Development to Imatinib under Increasing Selection Pressure: A Combination of Mathematical Models and In Vitro Data , 2011, PloS one.
[49] B. Druker,et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. , 2011, The Journal of clinical investigation.
[50] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.
[51] D. Waxman. A compact result for the time-dependent probability of fixation at a neutral locus. , 2011, Journal of theoretical biology.
[52] J. Dick,et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. , 1996, Blood.
[53] M. Kimura. Evolutionary Rate at the Molecular Level , 1968, Nature.
[54] H. Deeg,et al. New somatic mutation in the PIG-A gene emerges at relapse of paroxysmal nocturnal hemoglobinuria. , 1998, Blood.
[55] M Kimura,et al. SOLUTION OF A PROCESS OF RANDOM GENETIC DRIFT WITH A CONTINUOUS MODEL. , 1955, Proceedings of the National Academy of Sciences of the United States of America.
[56] C. Lassen,et al. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein , 2010, Proceedings of the National Academy of Sciences.